NSCLC can be divided into subclasses based on the presence of driver mutations in proteins such as epidermal growth factor receptor (EGFR), anaplastic lymphoma kinase (ALK), and Kirsten rat sarcoma virus (KRAS). The gene discussed is ALK; the disease is non-small cell lung carcinoma.